Welltower (NYSE:WELL) Announces Quarterly Earnings Results

Welltower (NYSE:WELL) issued its quarterly earnings data on Monday. The real estate investment trust reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.03, Briefing.com reports. The company had revenue of $3.72 billion for the quarter, compared to the consensus estimate of $3.64 billion. During the same period in the previous year, the business posted $1.34 earnings per share. The firm’s revenue was up 38.4% compared to the same quarter last year.

Welltower Trading Down 5.5%

Welltower stock opened at $227.36 on Wednesday. The business’s 50-day simple moving average is $233.79 and its 200 day simple moving average is $217.56. Welltower has a 12-month low of $174.91 and a 12-month high of $255.20.

Welltower Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 19th. Stockholders of record on Tuesday, November 10th will be paid a dividend of $0.85 per share. This represents a $3.40 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Tuesday, November 10th.

Insider Buying and Selling

In other Welltower news, Director Andrew Gundlach bought 5,000 shares of the business’s stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of $242.06 per share, for a total transaction of $1,210,300.00. Following the transaction, the director owned 30,000 shares in the company, valued at approximately $7,261,800. This trade represents a 20.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. 0.37% of the stock is currently owned by insiders.

Trending Headlines about Welltower

Here are the key news stories impacting Welltower this week:

• Positive Sentiment: Strong FFO and senior-housing fundamentals supported the stock. Normalized FFO rose 24.6% year over year to $1.67 per share, exceeding the $1.64 consensus estimate. Same-store net operating income increased 15.8%, while the Seniors Housing Operating portfolio posted 21.0% growth. Occupancy improved by 320 basis points and revenue per occupied room increased 5.3%. Welltower Reports Third Quarter 2026 Results
• Positive Sentiment: Management raised its full-year 2026 outlook. The improved guidance reflects momentum in the senior-housing operating portfolio, stronger occupancy and margins, and benefits from recent investments. Welltower has also closed or committed to approximately $21 billion of pro rata investments year to date, including $2.7 billion of senior-housing acquisitions during the quarter. WELL’s Q3 FFO Beat Estimates
• Neutral Sentiment: The quarterly dividend was maintained at $0.85 per share, equal to $3.40 annually and an indicated yield of roughly 1.5%. The payment is scheduled for November 19, with November 10 as the ex-dividend date. Welltower Declares Cash Dividend
• Negative Sentiment: Reported earnings and revenue concerns overshadowed the FFO beat. Some coverage characterized the quarter as an earnings miss, likely reflecting investor focus on reported net income and the quality or composition of revenue rather than FFO. The conflicting headlines contributed to profit-taking after Welltower’s substantial long-term advance.
• Negative Sentiment: Potential share issuance may be weighing on sentiment. Welltower filed prospectus supplements covering the potential issuance of additional common shares. Although the filings do not necessarily mean shares will be sold immediately, investors may view the possibility of dilution as a near-term overhang.

Wall Street Analyst Weigh In

A number of research firms have commented on WELL. Wells Fargo & Company boosted their price target on shares of Welltower from $266.00 to $268.00 and gave the company an “overweight” rating in a research report on Monday, October 19th. Morgan Stanley upped their price objective on shares of Welltower from $215.00 to $251.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 1st. Citigroup raised their price objective on shares of Welltower from $255.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Welltower from $215.00 to $265.00 and gave the company a “buy” rating in a research note on Wednesday, July 1st. Finally, UBS Group reissued a “buy” rating and issued a $269.00 target price on shares of Welltower in a report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $255.76.

About Welltower

Welltower Inc (NYSE: WELL) is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company’s senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.